Navigation Links
Innovative yeast genome may handle Cancer Clues

According to scientists mapping of have mapped all the genes in a second type of yeast that they hope will provide new insights into basic cell biology and the development of cancer.A team of international scientists led by Nobel medicine laureate Sir Paul Nurse of the charity Cancer Research UK has sequenced the genome of fission yeast, a cousin of the brewer's yeast whose genome// was mapped.

Fifty of the 4,000 genes in the fission yeast genome, which is reported in the science journal Nature, are similar to genes linked to human diseases such as cystic fibrosis, hereditary deafness, diabetes and cancer.

By studying the smaller and simpler genome of fission yeast, scientists hope to discover new clues about cells and how diseases like cancer develop in humans. "Many decisions the humble yeast cell makes in cell division use genes that are closely related to genes implicated in many human cancers: this small organism could prove vital in helping to better understand and treat cancer and other disease," said Nurse.

Fission yeast, or Schizosaccharomyces pombe, is the sixth and smallest genome of organisms, including humans, whose cells contain a nucleus to be decoded. Humans have an estimated 30,000-40,000 genes while brewer's yeast, the nematode worm, fruit fly and mustard weed, which have all been mapped, have between 6,000 and 26,000 genes. Professor Gordon McVie, a co-director with Nurse of Cancer Research UK, said comparing the genetic makeup of different species would improve the understanding of the basic biology behind cancer.

"Cells are the basic blocks upon which life is built, and by understanding how they grow and develop, we will be able to develop new treatments to fight cancer; this research will help toward that goal," McVie said in a statement.

Nurse and his British colleague Tim Hunt and American Leland Hartwell, of the Fred Hutchinson Cancer Research Center in Seattle, shared the 2001 N
'"/>




Page: 1 2

Related medicine news :

1. Innovative device aids in advanced heart failure
2. Innovative footwear may prevent fall in elderly
3. Innovative solution to help reduce the waiting times for kidney transplants
4. Personalized Medicine and Innovative Pharmaceuticals
5. Creation of Cytomegalovirus Vaccine by an Innovative Method
6. Innovative Method for Creating a Human Cytomegalovirus Vaccine Outlined
7. Innovative treatment for Dementia
8. Innovative treatment for Skin Cancer
9. Innovative Movies Show Real-Time Immune-Cell Activity within Tumors
10. Research In A New Direction To Develop Innovative Psychotropic Drugs
11. Autism Expert Creates Innovative Intervention Program
Post Your Comments:
(Date:7/25/2008)... Management to discuss second quarter financial re.../ - Labopharm Inc. (TSX: DDS;,NASDAQ: DDSS) today ...riday, August 8 at 8:30 a.m. (ET) to discuss its s...ll report its second quarter 2008 financial,result...same day., To access the conference call by telep...
(Date:7/25/2008)...f certain cleaning products reduces lung function,... , FRIDAY, July 25 (HealthDay News) -- A clean, ...ealth, depending on what type of cleaning and air ...suggests that exposure to cleaning products or air...c compound (VOC) called 1,4 dicholorobenzene (1,4 ...
(Date:7/25/2008)...ALLAS, July 25 /PRNewswire/ -- BeaconEquity.com an... making news today., Investors can view all of th...//BeaconEquity.com/m , Today,s Trade Alerts inclu...ddleBrook Pharmaceuticals Inc. (Nasdaq: MBRK ), N... ADLR ), Affymetrix Inc. (Nasdaq: AFFX ) and,Abax...
(Date:7/25/2008)... - 180-Days of Marketing Exclusivity Beg...all/ -- Watson,Pharmaceuticals, Inc. (NYSE: WPI )...unced today that its subsidiary has commenced comm...Capsules USP product in the 40mg,strength from its...tion,with the launch, Watson has 180 days of marke...
Breaking Medicine News(10 mins):Health News:Labopharm to host conference call Friday, August 8, 2008 at 8:30 A.M. (ET) 2Health News:Health Hazards in Household Cleaners Exposed 2Health News:Health Hazards in Household Cleaners Exposed 3Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:Watson Launches Omeprazole Delayed-Release Capsules, 40MG 2
...ot find the much needed reprieve yet. There are no...atening to plunge Queensland into a// deeper crisi...espite Premier Peter Beattie’s promises to the con...ike mere rhetoric when the Premier promised to bea...
... has become the number one killer. More so, relate...n occupational Hazard// with millions of people ru...place of work. Inhaling asbestos fibers and second...according to a WHO reports. Thousands develop leuk...
... the death of six pre-term babies in Quebec has fi...re the incidents// occurred-Quebec’s Sainte- Justi...g in faulty sinks of the neo-natal intensive care ...sa was discovered to be breeding in colonies withi...
...etic risk factors for type 2 diabetes to date, a U...ith two other groups, has identified// at least fo...risk of diabetes and confirmed existence of anothe...d simultaneously today in the online edition of th...
Other Medicine News:Health News:Today Cancer is the Deadliest Killer 2Health News:Tiny Lives Snuffed Out Due To Bad Plumbing 2Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 2Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 3Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 4Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 5Health News:Researchers Identify New Genetic Risk Factors for Type 2 Diabetes 6
(Date:7/22/2008)... 22 /- Following a,thorough...f Progen,Pharmaceuticals Limited (ASX: PGL; Nasdaq...he PI-88 phase 3 study in liver cancer. Progen con...ting portfolio of compounds and,the company will a...pportunities through Merger & Acquisition activity...
(Date:7/22/2008)...peutics Development Initiative bring MJFF,s,curren...ine January 20,2009, NEW YORK, July 22 /PRNewswi...delivery of transformative treatments and a cure f...ion for Parkinson,s Research has awarded,$2.7 mill...s. The awards,were granted under MJFF,s Therapeuti...
(Date:7/22/2008)... Confirms Tyrima Exhibits Excellent Drug-Like ...lts Support Initiation of Phase II Clinical Trials...wire/ -- CeNeRx BioPharma,Inc., a clinical stage ...treatments for diseases of the central nervous sys...didate Tyrima(TM) into Phase II trials for the,tre...
(Date:7/22/2008)...f., July 22 /- Hyperion,Therapeutics,...t enrollment,in its Phase 1/2 clinical trial to ev...ging effects of HPN-100 (formally called GT4P) ver...s with urea cycle disorders,(UCD). The company pla...ter,of this year., (Logo: http://www.newscom.com...
Breaking Medicine Technology:Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 2Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A 3Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 2Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinson's Therapeutics 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 2Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders 3Easy Does It Eases Holiday Stress 8766 1Easy Does It Eases Holiday Stress 8766 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 1Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 2Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis 8762 3Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 1Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 2Sinovac Reports Top Line Preliminary Phase II Results of Pandemic Influenza 28H5N1 29 Whole Viron Vaccine 2375 3Gold nanoparticle probes may allow earlier cancer detection 8756 1Gold nanoparticle probes may allow earlier cancer detection 8756 2Gold nanoparticle probes may allow earlier cancer detection 8756 3
Rotating 360 degrees, 3 mm x 7 mm bite.
Right side cutting.
Backward cutting, 3 mm x 7 mm bite, length of shaft 100 mm, overall length 7 inches.
20 mm. Plastic, methylmethacrylate. Supplied sterile.
Medicine Products: